Standard Chem & Pharm Co Ltd banner

Standard Chem & Pharm Co Ltd
TWSE:1720

Watchlist Manager
Standard Chem & Pharm Co Ltd Logo
Standard Chem & Pharm Co Ltd
TWSE:1720
Watchlist
Price: 61.9 TWD 0.16% Market Closed
Market Cap: NT$11.1B

EV/EBIT

7
Current
10%
Cheaper
vs 3-y average of 7.8

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
7
=
Enterprise Value
NT$10.2B
/
EBIT
NT$1.4B

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
7
=
Enterprise Value
NT$10.2B
/
EBIT
NT$1.4B

Valuation Scenarios

Standard Chem & Pharm Co Ltd is trading below its 3-year average

If EV/EBIT returns to its 3-Year Average (7.8), the stock would be worth NT$68.87 (11% upside from current price).

Statistics
Positive Scenarios
4/4
Maximum Downside
No Downside Scenarios
Maximum Upside
+198%
Average Upside
93%
Scenario EV/EBIT Value Implied Price Upside/Downside
Current Multiple 7 NT$61.9
0%
3-Year Average 7.8 NT$68.87
+11%
5-Year Average 7.5 NT$65.96
+7%
Industry Average 17.8 NT$157.7
+155%
Country Average 20.9 NT$184.5
+198%

Forward EV/EBIT
Today’s price vs future ebit

Not enough data available to calculate forward EV/EBIT

Peer Comparison

All Multiples
EV/EBIT
P/E
All Countries
Close
Market Cap EV/EBIT P/E
TW
Standard Chem & Pharm Co Ltd
TWSE:1720
11.1B TWD 7 11.9
US
Eli Lilly and Co
NYSE:LLY
867B USD 30.3 42
US
Johnson & Johnson
NYSE:JNJ
555.4B USD 21.6 26.4
CH
Roche Holding AG
SIX:ROG
248.4B CHF 12.9 19.3
UK
AstraZeneca PLC
LSE:AZN
224.8B GBP 22.7 29.1
CH
Novartis AG
SIX:NOVN
221.8B CHF 15.9 20
US
Merck & Co Inc
NYSE:MRK
283.6B USD 11.8 15.5
IE
Endo International PLC
LSE:0Y5F
244.4B USD 970 -83.6
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK 9.3 10.7
US
Pfizer Inc
NYSE:PFE
152.4B USD 10 19.5
US
Bristol-Myers Squibb Co
NYSE:BMY
118.8B USD 8.8 16.9
P/E Multiple
Earnings Growth PEG
TW
Standard Chem & Pharm Co Ltd
TWSE:1720
Average P/E: 21.1
11.9
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
42
32%
1.3
US
Johnson & Johnson
NYSE:JNJ
26.4
8%
3.3
CH
Roche Holding AG
SIX:ROG
19.3
14%
1.4
UK
AstraZeneca PLC
LSE:AZN
29.1
25%
1.2
CH
Novartis AG
SIX:NOVN
20
14%
1.4
US
Merck & Co Inc
NYSE:MRK
15.5
14%
1.1
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -83.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
10.7
0%
N/A
US
Pfizer Inc
NYSE:PFE
19.5
22%
0.9
US
Bristol-Myers Squibb Co
NYSE:BMY
16.9
16%
1.1

Market Distribution

Lower than 94% of companies in Taiwan
Percentile
6th
Based on 671 companies
6th percentile
7
Low
0.2 — 14.9
Typical Range
14.9 — 30.2
High
30.2 —
Distribution Statistics
Taiwan
Min 0.2
30th Percentile 14.9
Median 20.9
70th Percentile 30.2
Max 1 677.9

Standard Chem & Pharm Co Ltd
Glance View

Market Cap
11.1B TWD
Industry
Pharmaceuticals

Standard Chemical & Pharmaceutical Co., Ltd. engages in the manufacture and sale of Chinese and western medicine, medicine raw materials, and health food. The company is headquartered in Tainan, Tainan. The Company’s products cover drugs for circulation systems, digest systems, respiratory systems, nervous systems and other diseases. Through its subsidiaries, the Company is also engaged in the sales of medical equipment, animal medicine, milk powder, cosmetics and others. The firm distributes its products both in domestic markets and overseas markets.

Intrinsic Value
89.66 TWD
Undervaluation 31%
Intrinsic Value
Price NT$61.9
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett